was amplified, cloned into the pGEM-T Easy Vector (Promega, Madison, Wis., USA), and sequenced (8) . The nucleotide and deduced protein sequences were analyzed using the BLAST search engine and online ESBL genotyping tool (http://sunlight.informatik.unikiel.de:8180/amino/) and compared with other SHV sequences available from the Lahey website (http://www. lahey.org/studies/webt.htm). Compared with the SHV-1 sequence (GenBank accession no. AF148850), the novel SHV sequence contained seven nucleotide substitutions, resulting in changes in two non-synonymous amino acids, Leu35Gln and Ala146Val. The amino acid changes have been reported either alone or in combination with other substitution(s) in several SHV types. The SHV gene demonstrated the highest sequence similarity with SHV-11 (GenBank accession no. X98101), SHV-38 (GenBank accession no. AY079099), and SHV-80 (Gen-Bank accession no. AM176555), except for one amino acid difference. The novel SHV type was named SHV-144 (http://www.lahey.org/studies/webt.htm), and the nucleotide sequence was deposited in the Gen-Bank database under the accession no. JQ926986. Besides SHV-144, antibiotic resistance genes, including CTX-M-15, TEM-1, qnrB6, aac(6?)-Ib-cr, and sul1, were also detected in the bacterial strain.
To test the transmissibility of the SHV-144 gene, a conjugation experiment was conducted by broth mating of strain K24 with Escherichia coli strain J53 AzR (9) . Plasmid DNA was extracted from strain K24 and the E. coli transconjugant strain (strain K24-T) using a plasmid midi kit (Qiagen, Hilden, Germany). Three plasmids were identified from strain K24, but only one plasmid with an estimated size of approximately 100 kb was successfully transferred to the transconjugant strain. The SHV gene was not amplified from the total plasmid preparation of either strain K24 or the transconjugant (strain K24-T). These findings suggested that the gene was most likely located on the bacterial chromosome. However, hybridization analysis will be required to demonstrate the chromosomal location of the SHV gene.
The transconjugant strain demonstrated an ESBL phenotype, which was detected by the same method as that described for the donor (strain K24). MICs for the donor, recipient, and transconjugant strains are shown in Table 1 . Plasmid-mediated CTX-M-15, TEM-1, qnrB6, aac(6?)-Ib-cr, and sul1 genes were detected in the transconjugant strain, which explains the significantly higher MICs of ceftazidime, cefotaxime, aztreonam, ciprofloxacin, and trimethoprim/sulfamethoxazole for the transconjugant strain compared with those for the recipient strain. Although there were no apparent significant differences between the MICs of antimicrobials obtained for the donor and transconjugant strains, lower MICs of ceftazidime and ciprofloxacin were observed for the transconjugant strain, which could be due to other factors (such as drug permeability, efflux pumps, and chromosomal gene mutations) known to affect susceptibility to these antibiotics (10) .
To investigate the genetic relationship between strain K24 and other multidrug-resistant K. pneumoniae clinical isolates, pulsed-field gel electrophoresis (PFGE) was performed for 92 multidrug-resistant K. pneumoniae isolates collected from 2010 to 2011 in our hospital (11) . PFGE results indicated that strain K24 was genetically unrelated to any other isolates investigated during the study period ( Fig. 1) .
To date, there is little information regarding the epidemiology of nosocomial infections caused by K. pneumoniae in our hospital. An outbreak caused by SHV-5 ESBL-producing K. pneumoniae was reported in the pediatric oncology unit of the UMMC from December 1997 to January 1998 (12) . In addition, sporadic cases of SHV-12 ESBL-producing K. pneumoniae have been reported, suggesting that the SHV-12 gene may have evolved from the SHV-5 gene by acquisition of an additional mutation (Leu35Gln) (13) . Therefore, we propose that strain K24 is a sporadic isolate, considering that it originated from a patient with underlying diseases. Hereafter, expression, purification, and kinetics should be studied for further characterization of the SHV-144 enzyme. Next generation sequencing may prove useful to provide further information regarding the genomic content of the isolate.
Antimicrobial selection pressure triggers the evolution of resistance in bacterial pathogens, which frequently results in the emergence of highly resistant strains. Furthermore, co-expression of multiple resistance genes allows bacteria to sustain antimicrobial selection pressure; hence, clonal expansion of multidrug-resistant strains is possible under favorable conditions (14) . Combating multidrug-resistant bacteria remains a tremendous challenge; therefore, periodic surveillance of emerging antimicrobial resistance and effective infection control measures are important to prevent further spread of drug-resistant organisms in hospital settings.
